In a diet-induced mouse model of diabetes supplemented with streptozotocin (STZ) administration, chronic GLP-1R stimulation partially rescued the decrease in beta cell mass [211], confirming the role of cAMP in morphological adaptation, even in the setting of decompensated diabetes. The gene discussed is GLP1R; the disease is diabetes mellitus.